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Introduction
On the evening of Saturday 31 August 1901, the celebrated French novelist Marcel
Proust wrote to his mother with characteristic intimacy, recounting his struggle to quell
a severe attack of asthma the previous day. Having suffered from periodic attacks of
asthma since the age of nine, Proust was familiar with the range of contemporary treat-
ments for the condition: over the years, he had been prescribed opium, caffeine, iodine,
and morphine (which had once been injected by his father, Dr Adrien Proust), his nose
had been cauterized numerous times, he had adopted a milk diet, and he had occasionally
attempted to relieve both his asthma and his hay fever by visiting health resorts, such as
Evian-les-Bains, on the shores of Lake Geneva. However, as his note to his mother sug-
gests, Proust’s favoured remedy involved the inhalation of smoke from anti-asthma
cigarettes or powders:
Ma che `re petite Maman,
‘Misery of miseries or mystery of mysteries?’ That is the title of a chapter in one of Dumas’s
novels, which would apply very well to me at the moment. Yesterday after I wrote to you I had
an attack of asthma and incessant running at the nose, which obliged me to walk all doubled up
and light anti-asthma cigarettes at every tobacconist’s I passed, etc. And what’s worse, I haven’t
been able to go to bed till midnight, after endless fumigations, and it’s three or four hours after
a real summer attack, an unheard of thing for me.
1
Proust was not alone in attempting to relieve his asthma with medicated cigarettes or
combustible powders. Throughout the late nineteenth and early twentieth centuries, the
inhalation of fumes from burning preparations of stramonium, lobelia, tobacco, and
potash became increasingly popular amongst asthmatics and their physicians throughout
the world. Of course, a growing clinical reliance on anti-asthma smoking remedies of
this nature did not occur in a social or cultural vacuum. The preference for inhaling
smoke from stramonium and other substances coincided precisely both with the gradual
increase in smoking cannabis and opium for recreational and medical purposes and with
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171the rising popularity of smoking tobacco, initially in pipes and cigars and, after the
introduction of mass production techniques in the 1880s, in the form of cigarettes. As
Matthew Hilton has argued, although tobacco had been introduced into Britain from
Amerindian cultures in the sixteenth century, it was from the late nineteenth century
through to the middle decades of the twentieth century that smoking occupied an increas-
ingly important space “at the heart of British popular culture”: “By the mid-twentieth
century, four-fifths of adult men and two-fifths of adult women were smoking, a figure
which works out at 7 lb of tobacco per adult (aged over fifteen, smoking and non-smoking)
per year.”
2
A number of excellent historical studies have recently explored in detail the rapid
expansion of the tobacco industry during those years, the increasing dependency of
modern populations on tobacco products, the contested and politicized debates about
smoking and disease, and the efforts of modern governments and anti-smoking pres-
sure groups both to regulate the sale and advertising of tobacco and to compensate
smokers and their families for tobacco-induced cancers. In the British context, the
pioneering work of Jordan Goodman and Matthew Hilton has been reinforced and
extended by a collection of papers on smoking and health edited by Stephen Lock,
Lois Reynolds and E M Tansey, by Rosemary Elliot’s study of patterns of smoking
amongst women since 1890, and by Virginia Berridge’s close analysis of changing
perceptions of smoking within the context of scientific debates about the links
between smoking and cancer and shifting discourses of public health during the
last half of the twentieth century.
3 From a North American perspective, Allan
Brandt’s monumental study, The cigarette century, draws heavily on a wide range
of tobacco industry archives, recently made available as the result of litigation, to
expose the strategies adopted by the tobacco industry to protect their commercial
interests by rejecting or delaying the acceptance of scientific evidence that had estab-
lished the harm induced by tobacco products.
4
Not surprisingly, these recent histories of smoking have been preoccupied with
the manner in which the cigarette has “deeply penetrated” modern cultures,
5 resulting
in the rising prevalence of, and mortality from, a range of smoking-related illnesses,
including many cancers, cardiovascular disease, chronic bronchitis and emphysema.
The outcome has been a series of provocative scholarly studies with direct relevance
to on-going debates about health education, health promotion, and the political economy
2Matthew Hilton, Smoking in British popular
culture 1800–2000, Manchester University Press,
2000, pp. 1–2. For a broad discussion of the early
history of tobacco consumption, see also Jordan
Goodman, Tobacco in history: the cultures of
dependence, London, Routledge, 1993. For accounts
of smoking opium and cannabis, particularly during
the nineteenth century, see Virginia Berridge, Opium
and the people: opiate use and drug control policy in
nineteenth and early twentieth century England,
London, Free Association Books, 1999; James H
Mills, Cannabis Britannica: empire, trade, and
prohibition, Oxford University Press, 2003; Louise
Foxcroft, The making of addiction: the ‘use and
abuse’ of opium in nineteenth-century Britain,
Aldershot, Ashgate, 2007.
3Stephen Lock, Lois Reynolds and E M Tansey
(eds), Ashes to ashes: the history of smoking and
health, Amsterdam, Rodopi, 1998; Rosemary Elliot,
Women and smoking since 1890, New York and
London, Routledge, 2008; Virginia Berridge,
Marketing health: smoking and the discourse of
public health in Britain, 1945–2000, Oxford
University Press, 2007.
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America, New York, Basic Books, 2007.
5Ibid., p. 3.
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172of global industrial regulation. Yet, it is interesting to reflect that until the twentieth cen-
tury doctors “paid little attention to smoking as a health hazard”,
6 preferring instead to
emphasize the perceived health benefits of tobacco and other inhaled substances, and
that medicated cigarettes marketed for respiratory complaints continued to be endorsed,
and smoked, by doctors until well after the Second World War.
In spite of a rich historical literature on the consumption and regulation of tobacco,
opium and cannabis on both sides of the Atlantic, and apart from occasional references
to the role of smoking in reducing stress and facilitating relaxation, there has been little
historical interest in the therapeutic applications of smoking.
7 The principal aim of this
article is to explore the history of smoking as a remedial or curative technique intended
to facilitate the delivery of drugs to diseased lungs. Focusing on the treatment of asthma,
it situates the rise and fall of therapeutic smoking not only within the context of shifting
cultural and clinical perceptions of smoking tobacco, opium, and cannabis, but also
within the context of changing medical theories of asthma and fluctuating commercial
interest in inhalational treatments for respiratory disease. The first section explores
pre-modern approaches to inhalational treatments for asthma, tracing developments
from ancient Eastern and Western emphases on inhaling smoke from therapeutic plants
through to late-eighteenth-century debates about the relative merits of inhaled and sys-
temic drug administration in asthma. In the first decade of the nineteenth century, the
practice of smoking stramonium was introduced into Britain and other European coun-
tries from India, prompting a resurgence of interest in inhalational treatments. The sec-
ond section analyses the gradual proliferation of medical and public support for the
smoking cure for asthma, leading to its prominent position in the arsenal of available
remedies for asthmatics such as Marcel Proust. The final section examines the ways in
which changing theories of asthma, developments in the pharmaceutical industry, the
incremental proscription of dangerous drugs, and a growing recognition of the health
impacts of smoking gradually served to undermine the use of anti-asthma cigarettes
and powders.
Inhalational Treatments for Asthma prior to the Nineteenth Century
As a number of brief histories of inhaler technologies have indicated, most ancient
cultures recommended inhaling smoke from burning certain plants for both therapeutic
and recreational purposes.
8 In South America, for example, the smoke generated from
6Berridge, op. cit., note 3 above, p. 12.
7Some detailed histories of smoking do refer, but
only in passing, to the role of smoking in reducing
stress, see Berridge, op. cit., note 3 above, p. 12. The
broader health effects of tobacco are explored in R B
Walker, ‘Medical aspects of tobacco smoking and the
anti-tobacco movement in Britain in the nineteenth
century’, Med. Hist., 1980, 24: 391–402. Historical
studies of opium also include some discussion of the
variable impact on health of smoking those
substances: Berridge, op. cit., note 2 above, pp.
195–205; Foxcroft, op. cit., note 2 above, pp. 72–4.
8Jay Grossman, ‘The evolution of inhaler
technology’, Journal of Asthma, 1994, 31: 55–64;
Noel Snell, ‘Inhalation devices: a brief history’,
Respiratory Disease in Practice, summer 1995:
13–15; Jean-Fran¸ cois Dessanges, ‘A history of
nebulization’, Journal of Aerosol Medicine, 2001, 14:
65–71; Paula J Anderson, ‘History of aerosol therapy:
liquid nebulization to MDIs to DPIs’, Respiratory
Care, 2005, 50: 1139–50; Mark Sanders, ‘Inhalation
therapy: an historical review’, Primary Care
Respiratory Journal, 2007, 16: 71–81.
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173narcotic agents, such as opium, henbane and thorn-apple, was inhaled for its hallucino-
genic properties, and tobacco smoke was regularly employed as a diagnostic and thera-
peutic agent in shamanistic healing rituals.
9 In ancient India, inhaled smoke acquired
similar medical and ritualistic significance. As P Ram Manohar has suggested, within
the Indian context exposure to smoke incorporated a variety of practices and purposes:
homa, a religious fire offering intended to improve the general environment; dh  upa,a
form of fumigation carried out to protect people from both cold and demons; and dh  uma,
the predominantly therapeutic inhalation of smoke from a pipe, recommended by tradi-
tional   Ayurvedic practitioners. Although smoking was known occasionally to trigger
respiratory distress, inhaling smoke from herbal mixtures through a pipe was advocated
for the treatment of asthma and coughs, along with a variety of other respiratory condi-
tions.
10
Therapeutic smoking was also adopted elsewhere in the ancient world. Although
there remains some dispute as to whether ancient Egyptian doctors recognized a
form of breathing difficulty directly comparable with asthma, it is clear that the Ebers
Papyrus, compiled in approximately 1550 BC, did list remedies designed to remove
phlegm, alleviate catarrh and coughs, and ease breathing. Egyptian treatments for
respiratory distress included not only the oral consumption of a variety of concocted
vegetable, mineral and animal products, but also the delivery of active substances,
such as henbane and bitumen, directly to the lungs by inhalation: “Thou shalt fetch
7 stones and heat them by the fire, thou shalt take one thereof and place (a little)
of these remedies on it and cover it with a new vessel whose bottom is perforated
and place a stalk of a reed in this hole; thou shalt put thy mouth to this stalk, so
that thou inhalest the smoke of it.”
11
Inhalation was also recommended many centuries later by Greek and Roman physi-
cians, including Hippocrates, Dioscorides and Galen, for whom asthma constituted a
relatively discrete and moderately severe form of dyspnoea, or breathing difficulty,
accompanied by a wheeze and cough. Ancient Greek remedies for asthma focused lar-
gely on promoting a healthy lifestyle, supplemented when necessary by blood-letting
and evacuations, in order to restore humoral balance and to prevent or remove the accu-
mulation of phlegm in the lungs. However, they also included herbal preparations and
resinous gums administered either in the form of a linctus or syrup or via an inhalational
device, which comprised a pot with a reed in the lid, similar to the apparatus used by
ancient Indian practitioners.
12
Ancient modes of treatment were tailored to dominant models of disease. Most ancient
medical systems, whether developed in the East or the West, understood asthma to be the
product of excess phlegm accumulating in, and obstructing, the lungs of those with cold,
9Goodman, op. cit., note 2 above, pp. 19–36.
10P Ram Manohar, ‘Smoking and   Ayurvedic
medicine in India’, in Sander L Gilman and Zhou
Xun (eds), Smoke: a global history of smoking,
London, Reaktion Books, 2004, pp. 68–75.
11B Ebbell (tr.), The Papyrus Ebers: the greatest
Egyptian medical document, Copenhagen, Levin and
Munksgaard, 1937, p. 67.
12Snell, op. cit., note 8 above; Robert Bree,
A practical inquiry on disordered respiration;
distinguishing convulsive asthma, its specific causes,
and proper indications of cure, Birmingham,
M Swinney, 1797, p. 375.
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174moist constitutions: it was for this reason that asthma was often considered to be more
common in children and women. Within this conceptual framework, the inhalation of
smoke and fumes was intended to relieve the obstruction by heating and drying the
phlegm and aiding expectoration.
13 In the western medical tradition, this approach to
the pathogenesis and treatment of asthma persisted throughout the middle ages. Relying
heavily on the works of Hippocrates and Galen, medieval Islamic and Arabic scholars,
such as al-R  az   , Yuh
_
ann  a ibn Sarab     un and Ibn S   n  a, continued to advocate inhalation
as a means of loosening “thick and phlegmatic humor” in the lungs.
14 In his Kit  ab al-
Q  an  un f  ı al-t
_
ibb or Canon of medicine, for example, Ibn S   n  a recommended inhaling
fumes from both arsenic and sulphur.
15
Inhalations were also recommended by the Jewish scholar Rabbi Moses ben Maimon
(Maimonides), who wrote the first extensive treatise on asthma in the late twelfth century.
Drawing predominantly on ancient Greek preoccupations with redressing humoral imbal-
ance, Maimonides advocated adopting a suitable lifestyle: “a good regimen”, he argued,
“prolongs the interval between the cycles, diminishes the occurrences [of attacks] in a
cycle, alleviates the suffering and pain which they cause, and makes it easier to bear
them.”
16 While Maimonides thus encouraged physicians and patients to pay close atten-
tion to the six non-naturals (food and drink, environment, exercise, sleep, evacuations,
and emotions) and to the frequency of sexual intercourse, he also acknowledged the
role of “fumigations” in relieving asthmatic paroxysms: “As for the time of the attack,
[physicians] in our time have mentioned fumigations which strengthen the brain and
dry its superfluous moistures and prevent them from streaming. One of these is aloe
[aloe vera]; they have said to cast it onto a fire so that its vapor enters the nostrils and
the mouth, for it is a tried and true remedy.”
17
Transmitted through medieval Arabic, Islamic and Jewish scholarship, the writings
of Hippocrates and Galen continued to exert an influence on the clinical management
of asthma. However, it is clear that theories of asthma began to change during the
Renaissance and early modern periods and that ancient approaches to treatment,
including the inhalation of smoke, were increasingly challenged. This move away
from ancient remedies is evident in accounts of the treatment devised by the Italian
physician and mathematician, Girolamo Cardano, who in 1551 was invited to Scot-
land to attend John Hamilton, the Roman Catholic archbishop of St Andrews, whose
asthma had persisted in spite of the close attention of his physician. Cardano, who
was familiar with Maimonides’s treatise, suggested that Hamilton’s asthma was the
product not only of a life of luxury, venery and excessive work, but also of his
physician’s misguided attempts to treat him in hot, smoky rooms. The successful regi-
men devised by Cardano involved applying specific remedies aimed at purging and
13For more detailed discussion, see Mark
Jackson, Asthma: the biography, Oxford University
Press, 2009.
14For an English version of Ibn Sarab     un’s work,
see Luke Demaitre, ‘Straws in the wind: Latin
writings on asthma between Galen and Cardano’,
Allergy and Asthma Proceedings, 2002, 23: 59–93.
15Ibid.
16Gerrit Bos (ed.), Maimonides: On asthma,
Provo, Utah, Brigham Young University Press, 2002,
p. 5.
17Ibid., p. 73.
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175cooling, rather than heating, the body and pursuing a moderate, restrained and restful
lifestyle.
18
During the seventeenth century, western resistance to the therapeutic use of smoke inten-
sified, as innovativemechanicaland chemicalapproachesto disease served gradually to dis-
place ancient humoral theories. Neither the Flemish nobleman and physician John Baptista
van Helmont nor the English doctor Thomas Willis mentioned the use of smoking in their
accounts of asthma, even though both writers acknowledged that the accumulation
of phlegm in the lungs constituted a pivotal feature of the disease in many patients.
19
More critically, although the consumption of tobacco became increasingly popular across
Europe and was often recommended as a panacea, capable of relieving or curing a wide
range of illnesses,
20 some authors deliberately criticized the inhalation of tobacco smoke
in asthma. In A treatise of the asthma, first published in 1698, John Floyer dismissed both
theiatrochemicalspeculationsofwriters suchasvanHelmont andWillis andthe approaches
adopted by empirics. He argued instead, largely along humoral lines, that asthma was pri-
marily a systemic condition in which the balance of all bodily fluids (blood, chyle, lymph
and serum) was disturbed and the membranes of the stomach, lungs and head were
“inflated” or rigidly expanded, leading to a range of abdominal symptoms, headaches and
drowsiness as well as breathlessness.
21 Accordingly, Floyer preferred ancient Hippocratic
and medieval approaches to treatment, particularly the liberal use of “oxymel of squills”
combined with a suitable regimen, to reduce and prevent attacks. While Floyer noted that
“Syrup of Tobacco” had been recommended by van Helmont, he categorically rejected
the use of smoke: “All fumes of Tobacco, Amber, or Arsenic, are suffocating.”
22
Although Floyer’s treatise was translated into French and German and went through sev-
eral highly popular and influential English editions, his views on asthma were sometimes
rejected as impenetrable and idiosyncratic.
23 During the Enlightenment, clinical accounts
of asthma focused increasingly on the lungs and tended to refine the differentiation that
had originallybeenpostulatedbyvan Helmont and Willis between two distinct,but overlap-
ping, presentations of the disease: “humoral” or “spitting” asthma, characterized by the
accumulation of phlegm; and “nervous” or “convulsive” asthma marked by spasmodic con-
traction of the bronchi and minimal production of phlegm. For most late-eighteenth-century
commentators, the latter form of the condition was the most prominent. According to
William Buchan, William Cullen and Thomas Withers, asthma was caused primarily not
by the accumulation of phlegm or mucus, but by an “affection of the nervous system”, lead-
ing to “spasmodic, constriction of the muscular fibres of the bronchiae”.
24
18For more detailed discussion of Cardano’s
approach, see Alan Wykes, Doctor Cardano:
physician extraordinary, London, Muller, 1969;
Charles L Dana, ‘The story of a great consultation:
Jerome Cardan goes to Edinburgh’, Ann. Med. Hist.,
1921, 13: 122–35; Jackson, op. cit., note 13 above.
19John Baptista van Helmont, Oriatrike or,
Physick refined, London, 1662; Thomas Willis,
Pharmaceutice rationalis: or, The operations of
medicines in humane bodies, Part II, London, 1679.
20Walker, op. cit., note 7 above; Goodman, op.
cit., note 2 above.
21John Floyer, A treatise of the asthma, London,
Richard Wilkin, 1698.
22Ibid., pp. 207, 226.
23See, for example, the comments in Thomas
Withers, A treatise on the asthma, London, G G J and
J Robinson, 1786, pp. vii–viii.
24William Cullen, First lines of the practice of
physic, 4 vols, Edinburgh, 1784, vol. 3, pp. 390–410;
William Buchan, Domestic medicine, London, 1776,
pp. 441–5.
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176To some extent, renewed attention to the local pulmonary causes of asthma reinvigo-
rated clinical interest in inhaled therapies, although largely in the form of vapour rather
than smoke. In 1774, the anonymous author of Instant relief to the asthmatic suggested
that “inward applications” of medicines would be ineffectual because active ingredients
would be “separated and subtilized by the body” before reaching the lungs. Relief from
the asthmatic paroxysm was thus best achieved by the delivery of “volatilized matter,o r
aetherial essence” directly to the lungs. Inhaled vapours would divide “tough phlegm”,
aid expectoration, and relax the airways which were “affected with morbid contrac-
tions”.
25 The popularity of inhalation for asthma and other respiratory complaints was
boosted by the production of improved inhalers, particularly those invented and market-
ed during the 1760s and 1770s by the English physicians Philip Stern and John Mudge.
As Stern argued in a pamphlet written in 1767 to advertise a “simple machine” (Figure 1)
devised to deliver anti-spasmodic medicines, such as his own “Balsamic Aether”,
directly to the seat of the disease, “the happiest effects may rationally be expected,
from such a medicine thus applied, by means of the steam of hot water, directly to the
injured lungs”.
26
However, many clinicians remained sceptical of the claims made for inhalational
therapies. At the end of the eighteenth century, for example, the potential benefits of
inhaling medicinal vapours and smoke were disputed by the English physician Robert
Bree, who, like Floyer, was plagued with chronic asthma. In A practical inquiry into
Figure 1: A simple machine devised by Philip Stern in 1767 to deliver medicines to the lungs of
patients with consumption and asthma. (Reproduced by kind permission of Wellcome Library,
London.)
25Anon., Instant relief to the asthmatic, or those
afflicted with shortness of breath, London, 1774,
pp. 22–3, 28–30.
26Philip Stern, Medical advice to the consumptive
and asthmatic people of England, London, J Almon,
1767, p. 22. For a similar pamphlet advertising his
own “inhaler”, see John Mudge, A radical and
expeditious cure for a recent catarrhous cough,
London, E Allen, 1778. On the inhalers themselves,
see Sanders, op. cit., note 8 above.
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177disordered respiration, first published in 1797, Bree noted that historically many physi-
cians, from Hippocrates onwards, had recommended inhaling vapours from frankincense,
myrrh and various gums in order to treat both asthma and phthisis.
27 Bree was uncon-
vinced. In some forms of asthma, he argued, moist inhalations only aggravated the symp-
toms, and the narcotic qualities of anti-spasmodic medication were more effective “taken
into the stomach” rather than the lungs. More particularly, Bree criticized asthmatics who
adopted the practice of “Smoaking Tobacco”, which, by increasing, rather than decreasing,
“serous secretion” in the bronchi, operated as a cause of asthma.
28 Although other medical
writers, such as George Lipscomb, rejected Bree’s particular formulation of asthma, they
tended to agree that fumigations were of limited value: “It is unnecessary to expatiate on
the inutility of fumigations of all kinds”, wrote Lipscomb in 1800, “nor do I think it worth
w h i l et oc o m b a tt h evisionary idea of aerial medicines being capable of subduing the vio-
lence of the paroxysm, before the serous effusion has been expectorated.”
29
Prior to the nineteenth century, then, the inhalation of vapours and smoke occupied a
variable place in the treatment of asthma in most western and eastern medical traditions.
Its use in many ancient medical systems, including   Ayurvedic, Egyptian and Greek med-
icine, stemmed from a dominant belief that asthma was the product of cold, moist
phlegm accumulating in the lungs. While the persistence of humoral theories supported
the continued use of inhalation throughout the medieval period, the application of smoke
and vapours in order to remove phlegm increasingly fell into disrepute during the early
modern period and Enlightenment as medical commentators began to emphasize the role
of nervous bronchospasm in the pathogenesis of asthma attacks. In spite of occasional
efforts to promote inhalation, most notably by the inventors and manufacturers of inha-
lers, by the end of the eighteenth century doubts about the efficacy and safety of inhaling
medicated vapours or smoke from tobacco and other herbs served to relegate inhalational
therapies to the margins of clinical practice. However, the introduction of stramonium
from India in the early nineteenth century operated as a catalyst that refocused clinical
attention on the therapeutic benefits of smoking for asthma.
Smoking Stramonium for Asthma
Theresurgenceofinterest,amongstBritishphysicians,insmokingforasthmawasadirect
product of the empire. The East India Company, a joint-stock company formed in the late
sixteenth century primarily to facilitate trade in cotton, silk, opium and other commodities,
had by the late eighteenth century established administrative and military power over much
of India. In 1802, Dr James Anderson, the Scottish-born physician-general in Madras whose
prime interest was the cultivation of silk,
30 notified William Gent, a major-general in the
Madras army, of an indigenous treatment for asthma. Gent relayed the details to an English
27Bree, op. cit., note 12 above, pp. 375–83.
28Ibid., pp. 377–8. For a comparable discussion
of the role of fumes and smoke in triggering asthma
attacks, see Withers, op. cit., note 23 above.
29George Lipscomb, Observations on the history
and cause of asthma, Birmingham, James Belcher,
1800, p. 99.
30James Anderson, The conclusion of letters on
the culture of silk, Madras, Joseph Martin, 1792;
James Anderson, Letters, &c., Madras, Bone and
Cooper, 1796.
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178physician, Dr Sims, who recommended the remedy to patients and colleagues and, con-
vinced of its value, advertised its efficacy in the medical press:
Some time in the year 1802, I received from General Gent a remedy that he had not long before
brought from Madras, which, the General informed me, was used there as a specific for relieving
the paroxysm of asthma, and that it was prepared from the roots of the wild purple-flowered thorn-
apple (Datura ferox). The roots had been cut into slips as soon as gathered, dried in the shade, and
then beat into fibres resembling coarse hemp. The mode of using it was by smoking it in a pipe at
the time of the paroxysm, either by itself or mixed with tobacco.
31
Having exhausted his supply of Indian Datura ferox, one of the beneficiaries of this
novel treatment, a surgeon in Hackney, turned for relief to the common thorn-apple,
Datura stramonium, which was also a member of the solanaceae family of plants that
included henbane, deadly nightshade and mandrake and which appeared to have similar
anti-spasmodic properties. Although the leaves and seeds of the thorn-apple were known
to have dangerous narcotic effects, leading to its being referred to as “the Devil’s Apple”
or one of the “witches’ weeds”, patient testimonies suggested that preparations of the
stalks and roots were effective in relieving asthmatic paroxysms:
You are perfectly at liberty to make every use of my name respecting the stramonium you think
proper, and may add, that I continue to derive increased good effects from the use of it. In truth,
the asthma is destroyed! I drink beer, eat of every thing; and if my mind was as free from perplex-
ity as my body is from asthma, I should again enjoy my existence. I never experienced torpor or
any ill effect whatever; and I would rather be without life than without stramonium.
32
Stramonium was enthusiastically adopted by asthmatic patients and their physicians.
In promoting its use as a pain-reliever in 1816, Alexander Marcet noted that Datura stra-
monium was often “cultivated in some English gardens” expressly for the purpose of
treating asthma.
33 During the following decades, most medical authorities on asthma
advocated smoking stramonium because of its anti-spasmodic properties. In 1819, the
French clinician and pathologist Rene ´ The ´ophile Hyacinthe Laennec included a discus-
sion of asthma in his study of the clinical value of auscultation. Believing that asthma
was more likely to be caused by spasmodic constriction of the bronchi than by the accu-
mulation of mucus, Laennec recommended a variety of anti-spasmodics, including
opium, belladonna, stramonium, tobacco, hyoscyamus and coffee.
34 In 1835, Francis
Ramadge, physician to the Infirmary for Asthma, Consumption and other Diseases of
the Chest in London, supported Laennec’s use of stramonium, noting that it also pro-
duced “a grateful forgetfulness and a balmy oblivion like opiates”.
35 Four years later,
31Anon., ‘Communications relative to the Datura
Stramonium, or thorn-apple: as a cure or relief of
asthma’, Edinb. Med. Surg. J., 1812, 8: 364–7, at
p. 365.
32Ibid., 367.
33Alexander Marcet, ‘On the medicinal properties
of stramonium; with illustrative cases’, Medico-
Chirurg. Trans., 1816, 7: 546–75.
34R T H Laennec, A treatise on the diseases of the
chest and on mediate auscultation, 2nd ed., tr. John
Forbes, London, T & G Underwood, 1827. The
French first edition appeared as R T H Laennec,
De l’auscultation me ´diate, Paris, J-A Brosson and
J-S Chaude ´, 1819.
35F H Ramadge, Asthma, its species and
complications, or Researches into the pathology of
disordered respiration, London, 1835, quoted in
Barry E Brenner, ‘Where have we been? The history
of acute asthma’, in Barry E Brenner (ed.),
Emergency asthma, New York, Marcel Dekker, 1999,
pp. 1–31, at p. 7.
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179in an article in the Lancet, A T Thomson recognized the practical obstacles to relying on
stramonium, but nevertheless argued that smoking stramonium offered one of the most
effective contemporary remedies for asthma:
In some instances he had observed almost immediate relief obtained from smoking stramonium;
but in cases such as that under consideration, in which the paroxysms returned early in the morn-
ing, and subsided in a few hours, the difficulty of obtaining the means of smoking it was one objec-
tion to its employment; at the same time he must confess it was one of the best means of shortening
the asthmatic paroxysm, and abating the sufferings of the patient, with which we were acquainted,
especially when the case has been of long standing, and the patient was of a nervous tempera-
ment.
36
The growing popularity of smoking for asthma was endorsed by two of the leading
nineteenth-century writers on the condition, the English physician Henry Hyde Salter,
who was himself asthmatic, and the French physician Armand Trousseau. Salter’s trea-
tise on asthma, first published in 1860, was particularly successful. Considered a defini-
tive text for many decades, it appeared in an American edition in 1864 and an expanded
second British edition in 1868, establishing Salter’s international reputation as an expert
in the field. Like Trousseau, who regarded asthma as a “diathetic neurosis” closely asso-
ciated with eczema and hives,
37 Salter subscribed to the nervous theory of asthma,
arguing that asthmatic symptoms were caused primarily by “a spastic contraction of
the fibre-cells of organic or unstriped muscle, which minute anatomy has demonstrated
to exist in the bronchial tubes”, rather than by catarrh or bronchitis. Salter’s approach
to treatment reflected this understanding of pathogenesis. In alleviating the paroxysms,
he emphasized the importance of avoiding or removing any known “exciting cause”,
as well as advocating the use of depressants such as ipecacuanha, tobacco and antimony
to suppress nervous irritation, stimulants such as strong black coffee, tea, ammonia, and
hot alcohol to divert “morbid activity” from the lungs, and a range of sedatives, includ-
ing tobacco, chloroform, stramonium and belladonna, to allay irritability.
38 Many of the
substances discussed by Salter had dual actions: Indian hemp or Cannabis sativa, which
was also becoming popular as a panacea in Britain following its introduction from India
and which was regularly recommended in the form of a tincture for asthmatics, was both
a stimulant and a sedative.
39
Salter’s discussion of the benefits of smoking stramonium was extensive. Although he
recognized that stramonium did not always guarantee relief, partly on account of the
“special caprice of asthma” and partly because of differences in the “mode of preparation
and drying of the drug”, he nevertheless acknowledged that its efficacy in some cases
always made it worth trying. Significantly, its action was amplified if the stramonium
were not merely smoked in a pipe (leading to absorption “by the oral surface only”),
36A T Thomson, ‘Clinical remarks on a case of
asthma’, Lancet, 27 July 1839, ii: 645–9, at p. 647.
37Armand Trousseau, Lectures on clinical
medicine, tr. P Victor Bazire, London, [1861], 1868.
38Henry Hyde Salter, On asthma: its pathology
and treatment, London, John Churchill and Sons,
1860, pp. 161–204. See also idem, ‘Spasmodic
asthma’, Lancet, 7 Jan. 1860, i: 12; idem, ‘On the
treatment of the asthmatic paroxysm by full doses of
alcohol’, Lancet, 14 Nov. 1863, ii: 558–9; idem, ‘On
the treatment of asthma by belladonna’, Lancet,
30 Jan. 1869, ii: 152–3.
39Salter, On asthma, op. cit., note 38 above,
p. 203. On the medical uses of cannabis in this period,
see Mills, op. cit., note 2 above.
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180but if the saliva was swallowed and the smoke inhaled “as much as possible into the
lungs”, which had the “advantage of being applied to the very parts affected”. According
to Salter, stramonium was more effective as a preventative than a cure. Indeed, he advo-
cated smoking a pipe each night before bed in order to “keep the disease at bay”: “The
stramonium seems to leave for some hours a state of nervous system in which the asthma
is not likely to come on; and, since the attack is almost always at night, the use of stra-
monium at bedtime conducts and guards the patient through the critical time.”
40
The rising popularity of smoking stramonium for asthma during the middle decades of
the nineteenth century can be traced to a variety of factors. In the first instance, it is evi-
dent that support for the therapeutic use of stramonium developed in tandem with med-
ical accounts of asthma as the product of spasmodic bronchoconstriction. Articulated
fully by William Cullen in the late eighteenth century, the spasmodic theory of asthma
gained support during the early nineteenth century, not only from the clinical studies
of Laennec but also from the work of the German physician Franz Daniel Reisseissen
and others, who demonstrated the presence of circular muscle fibres around the bronchi.
An emphasis on spasmodic constriction prioritized the application of anti-spasmodics,
including stramonium and tobacco. Indeed, it is likely that both theory and practice
were mutually reinforcing: while the spasmodic theory stipulated the use of anti-spasmo-
dics, the apparent efficacy of stramonium legitimated theories that explained asthma in
terms of nervous spasm rather than mucous obstruction.
41
It is also possible that the initial popularity of stramonium was at least partly linked to its
novelty. As Salter noted, smoking stramonium “soon obtained, as new remedies are apt to,
the reputation of being specific and infallible;—everybody with any shortness of breathing
[sic] was smoking stramonium”.
42 Although the limitations and dangers of smoking stramo-
nium were rapidly recognized, its continued success amongst asthmatics and their physi-
cians probably owed much to the absence of effective alternative remedies. Since
antiquity, asthma had often been regarded as an incurable disease; as the personal accounts
of many asthmatic physicians indicated, even persistent adherence to a suitable regimen for-
tified with specific herbal treatments offered only minimal relief from severe attacks of
asthma and only partial prevention of relapses. According to the Devon surgeon, Thomas
Pridham, many patients had consulted eminent physicians with little success and had
become resigned to “a life of suffering”, as one patient put it, “as no known remedy would
reach her disease”.
43 The promise, and reported delivery, of immediate relief for such
patients who had previously been “grievously harassed by asthma” proved seductive.
44
There were broader cultural and commercial determinants of the rising popularity of
stramonium and other smoking remedies for asthma. In the first instance, smoking itself
became an increasingly prominent leisure activity during the nineteenth century. As
Matthew Hilton has argued, during that period, smoking tobacco constituted a habit
or hobby that was promoted by bourgeois-liberal ideologies and became “central to
40Salter, On asthma, op. cit., note 38 above,
pp. 198–201.
41See the discussion in Jackson, op. cit., note 13
above, ch. 2.
42Salter, On asthma, op. cit., note 38 above,
p. 195.
43Thomas Pridham, ‘Observations on the
treatment of asthma’, Br. Med. J., 17 Nov. 1860, ii:
896–8.
44Ibid.
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181individual and group identity”: in Britain, smoking epitomized a vision of masculinity
that resonated with wider commitments to economic independence and liberal notions
of social superiority and individuality.
45 As many medical texts demonstrated, tobacco
was also thought to possess therapeutic, as well as recreational, potential. Tinctures, cly-
sters and injections of tobacco were recommended for the treatment of cholera, intestinal
obstruction and dropsy, and the smoke from mild tobacco was thought to be effective in
asthma, particularly in cases where asthmatic paroxysms were associated with hay
fever.
46 Of course, the clinical use of tobacco was not without its critics. As participants
in a vocal anti-tobacco movement, many medical commentators in the nineteenth century
highlighted not only the moral, but also the clinical, dangers of tobacco, including the
proliferation of heart disorders, insanity, tuberculosis, and impotence.
47 In addition, as
Salter noted, the prevalence of tobacco smoking amongst adult men often rendered
them less susceptible to the therapeutic effects of tobacco.
48 In spite of such anxieties
about the impact of smoking on patterns of health and disease, however, a growing cul-
tural dependence on tobacco consumption may well have promoted, or at least made
acceptable, smoking as a cure for asthma.
Tobacco was not the only substance smoked for both pleasure and symptomatic relief
during the middle decades of the nineteenth century. As recent studies by Virginia
Berridge, Louise Foxcroft and Jim Mills have suggested, the practice of smoking opium
and cannabis also spread rapidly during that period. In addition to their recreational use
as hallucinogens and relaxants, cannabis and opium were recommended as sedatives and
pain relievers, as stimulants of digestion, and as anti-asthma agents.
49 Although they
were usually administered orally for medicinal purposes and although smoking cannabis
and opium attracted considerable criticism amidst rising fears of addiction and degenera-
tion, inhaling the smoke from both also generated discussion amongst clinicians and in
the process reinvigorated longstanding debates about the relative efficacy of oral and
inhaled drugs. In 1842, Dr J Johnson’s notes on a paper published in the Lancet by
G H Smith suggested that “taking opium, by smoking or inhalation, induces the peculiar
sedative effects of that drug more powerfully and more speedily than when taken into the
stomach”.
50 Nearly thirty years later, the author of a pamphlet on opium similarly advo-
cated the need to pay greater attention to this mode of administration: “It might be useful
if the subject were investigated by medical men, to see if opium smoking might not be
found a convenient way of administering the drug to patients who otherwise cannot
take it without the stomach being upset.”
51 Although anxieties about the social implica-
tions of smoking cannabis and opium persisted, the rising popularity of smoking both
drugs for health and pleasure, particularly amongst radical intellectuals such as Proust,
52
may well have encouraged the acceptability of smoking stramonium for asthma.
45Hilton, op. cit., note 2 above, pp. 3–5.
46Walker, op. cit., note 7 above; Salter,
On asthma, op. cit., note 38 above,
pp. 166–76.
47Walker, op. cit., note 7 above.
48Salter, On asthma, op. cit., note 38 above,
p. 176.
49Berridge, op. cit., note 2 above; Foxcroft, op.
cit., note 2 above; and Mills, op. cit., note 2 above.
50G H Smith, ‘On opium smoking among the
Chinese’, Lancet, 19 Feb. 1841–2, i: 707–10, quote at
p. 710.
51Anon., What opium feels like. By one who has
tried it, (1870), John Burns Collection, Greater
London Record Office. See also Berridge, op. cit.,
note 2 above, p. 196; Foxcroft, op. cit. note 2 above,
p. 73.
52Berridge, op. cit., note 2 above, p. 204.
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182The smoking cure for asthma may also have been promoted by growing commercial
and clinical interest in inhalers and inhalational treatments for a wide variety of respira-
tory disorders during the mid-nineteenth century. Echoing earlier support for inhalational
therapies, in 1862 the North American physician Charles R Broadbent suggested that the
delivery of a wide range of “medicated vapours” directly to the lungs offered the most
effective remedy for consumption, laryngitis, chronic catarrh and other diseases of the
air passages, including asthma:
It seems to us like the climax of folly to attempt to affect a disease in the lungs through the medium
of the stomach, when by the simple and direct process of inhalation we can so readily gain access
to the whole mucous surface and remotest air cells in the lungs, and bring all the active and med-
icinal properties of the remedy employed, at once upon the part diseased.
53
Broadbent’s approach was facilitated by the development of inhalational anaesthesia,
which had been first introduced in the 1840s, and by the production of new inhalers from
the mid-1860s, both of which served to establish inhalation as a reputable form of drug
delivery. During the 1860s, for example, novel apparatuses for inhaling both dry powders
and vapours were successfully marketed for purchase by the general population: indeed,
the ceramic Nelson inhaler, first reported in the Lancet in 1865 and supplied by S Maw
and Sons in London, rapidly became (and remains) a well-recognized means of treating
many respiratory conditions. The first steam spray inhalers, forerunners of the modern
nebulizer, were also introduced during the 1860s and 1870s. As Mark Sanders has sug-
gested, medical acceptance of these innovations was evident in the decision to formular-
ize inhalation therapies in the 1867 edition of the British Pharmacopoeia.
54
Inhalational therapies offered pharmacy suppliers and entrepreneurs on both sides of
the Atlantic commercial opportunities to exploit contemporary fears about the prevalence
of, and mortality from, respiratory conditions such as consumption, asthma, bronchitis,
pneumonia, and influenza. During the closing decades of the nineteenth century, a vari-
ety of patent remedies were advertised in the press and distributed to the public. The
most notable of these inhaled treatments was the Carbolic Smoke Ball, patented by
Frederick Augustus Roe in 1889, which was recommended particularly for the treatment
of influenza and which subsequently became the subject of an extensive law suit,
55
but many others, such as John Francis Churchill’s inhalant “Spirone” advertised in the
Chemist and Druggist in 1890, flooded the market (Figure 2).
As the advertisements for both “Spirone” and the Carbolic Smoke Ball suggest, many
of these devices and inhalants were intended to treat a wide range of respiratory diseases,
including asthma. However, a number of inhaled remedies were targeted specifically at
asthma, either in the form of powders, which were to be burned in pipes or bowls and
the fumes inhaled, or increasingly in the form of cigarettes. Preparations such as Potter’s
53Charles R Broadbent, A medical treatise on the
causes and curability of consumption, laryngitis,
chronic catarrh, and diseases of the air passages,
Boston, Damrell and Welch, 1862, p. 48.
54Sanders, op. cit., note 8 above, p. 75.
55A W B Simpson, ‘Quackery and contract law:
the case of the Carbolic Smoke Ball’, Journal of
Legal Studies, 1985, 14: 345–89; Janice Dickin
McGinnis, ‘Carlill v. Carbolic Smoke Ball Company:
influenza, quackery, and unilateral contract’, Can.
Bull. Med. Hist., 1988, 5: 121–41. The full Court of
Appeal judgement is given in Carlill v. Carbolic
Smoke Ball Company, 1893, 1 QB 256.
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183Asthma Cure, Himrod’s Cure for Asthma (endorsed by the famous ear, nose and throat
specialist Morell Mackenzie), Asthmador Cigarettes, Dr J D Kellogg’s Asthma Remedy,
and Espic, Legras and Escouflaire powders, most of which contained stramonium either
alone or in conjunction with tobacco, lobelia, potash and sometimes arsenic, were
aggressively promoted in the medical and popular press and sold over the counter in
most western countries (Figure 3).
56 Although such remedies were occasionally criti-
cized because they were poisonous, because they were thought to increase bronchial irri-
tation and inflammation, or because systemic administration was thought to be
preferable,
57 by the end of the nineteenth century fumigations, inhalations and smoking
were regularly recommended by doctors and employed by patients in order to relieve and
prevent debilitating paroxysms of asthma.
58
Figure 2: An advertisement for “Spirone”, 1890. (Reproduced by kind permission of the Wellcome
Library, London.)
56For further examples of the range of medicated
powders and cigarettes available, see Mark Sanders’
collection at http://inhalatorium.com; National Library
of Medicine, Breath of life, Washington, 1998.
57On concerns about bronchial irritation and other
side effects, see Sidney Martin, ‘A clinical lecture on
asthma and its treatment’, Br. Med. J., 24 Dec. 1898, ii:
1861–3; J B Berkart, On bronchial asthma: its
pathology and treatment, London, Oxford University
Press, 1911, pp. 97–8. On the preference for oral
tinctures of stramonium or belladonna, see C Theodore
Williams, ‘The value of inhalations in the treatment of
lung disease’, Br. Med. J.,2 9S e p t .1 8 8 8 ,ii: 700–6.
58Walter Hayle Walshe, A practical treatise on
the diseases of the lungs, London, James Walton,
1871, pp. 552–3; E Symes Thompson, ‘Notes of a
lecture on hay-fever’, Br. Med. J., 21 Jan. 1871, i:
58–60.
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184Figure 3: An advertisement for Potter’s Asthma Cure, c.1910. (Reproduced by kind permission of
the Wellcome Library, London.)
185Widespread clinical and cultural acceptance of smoking for asthma is exemplified by
the persistent strategies adopted by Marcel Proust to relieve his breathlessness. Until his
mother’s death in 1905, Proust lived in his parents’ house in Paris, in which there was a
dedicated “smoking-room” where he regularly burned, and inhaled the smoke from,
commercial anti-asthma powders. In 1906, when Proust moved to an apartment on bou-
levard Haussmann, his bedroom was lined with cork to insulate him from external smells
and fumes that might trigger his asthma and hay fever, and the room would be “thick
with smoke” from repeated and prolonged fumigations.
59 Indeed, although Proust clearly
did smoke medicated cigarettes for his asthma when he was out, he preferred to employ
the combustible powders produced and marketed commercially by Espic, Legras or
Escouflaire: “This is the only thing that has ever given me any relief”, he explained to
his general housekeeper, Ce ´leste Albaret, who lived with Proust from 1913 until his
death. “I once tried the cigarettes made with this same Legras powder, but I am sure
the paper they use, though thin and carefully prepared, disagrees with me. I prefer just
the fumes.”
60 For Proust, as for many asthmatics at the dawn of the twentieth century,
inhaling the smoke from stramonium, lobelia and potash promised both the most
immediate and the most effective relief from what Henry Hyde Salter had described as
“the sense of impending suffocation, the agonizing struggle for the breath of life” that
accompanied an acute attack of asthma.
61
The Gradual Decline of Smoking for Asthma
Smoking medicated cigarettes and burning anti-asthma powders retained a central
position in the treatment of asthma during the early twentieth century. Indeed, many pro-
minent physicians continued to advocate the value of smoking stramonium and other
substances, including tobacco.
62 In the fourth edition of The principles and practice of
medicine, published in 1901, the Canadian physician and Regius Professor of Medicine
at Oxford, William Osler, highlighted the pivotal role of smoking and fumigating as
both therapeutic and prophylactic:
The sedative antispasmodics, such as belladonna, henbane, stramonium, and lobelia, may be given
in solution or used in the form of cigarettes. Nearly all the popular remedies either in this form or
in pastilles contain some plant of the order solanaceae, with nitrate or chlorate of potash. Excellent
cigarettes are now manufactured and asthmatics try various sorts, since one form benefits one
patient, and another form another patient. Nitre paper made with a strong solution of nitrate of
potash is very serviceable. Filling the room with the fumes of this paper prior to retiring will some-
times ward off a nocturnal attack. I have known several patients to whom tobacco smoke inhaled
was quite as potent as the prepared cigarettes.
63
59Ce ´leste Albaret, Monsieur Proust, ed. Georges
Belmont,London, Collins and HarvillPress, 1976, p. 63.
60Ibid., p. 62.
61Henry Hyde Salter, On asthma: its pathology
and treatment, 2nd ed., London, John Churchill and
Sons, 1868, p. 2.
62For a brief discussion of tobacco use in asthma
during the nineteenth and early twentieth centuries,
see H Silvette, P S Larson, and H B Haag, ‘Medical
uses of tobacco, past and present’, Virginia
Medical Monthly, 1958, 85: 472–84.
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186Osler’s support for smoking was reinforced by other physicians. As Eric K Chu and
Jeffrey M Drazen have suggested, smoking stramonium remained a recommended treat-
ment option for asthma in medical textbooks published throughout the early decades of
the twentieth century.
64 In addition, surveys and clinical studies conducted during the
1940s and 1950s continued occasionally to emphasize the therapeutic value of cigarettes
containing either stramonium or one of its active ingredients, atropine: “Atropine admi-
nistered locally in cigarette smoke or wet aerosols”, wrote H Herxheimer in 1959,
“increases the vital capacity and gives a feeling of relief in cases of mild or moderate
chronic asthma and emphysema.”
65
In spite of authoritative endorsements from clinicians and scientists, however, it is evi-
dent that even before Proust died in 1922 the popularity of smoking for asthma was
already under threat. Opposition to the smoking cure appeared from a variety of direc-
tions. In the first instance, it is evident that declining support for smoking was prompted
partly by new, allergic understandings of asthma that prioritized inflammation rather
than nervous bronchoconstriction. The term allergy had been introduced in 1906 by
the Austrian paediatrician Clemens von Pirquet in order to describe a range of clinical
manifestations characterized by altered immunological reactivity or hypersensitivity.
Within four years, Samuel Meltzer, a leading American physiologist and founder of
the Society of Experimental Biology and Medicine, had suggested that asthma should
be seen primarily as the product of an anaphylactic or allergic inflammatory response,
rather than as the result of a neurosis.
66
Accounts of asthma that emphasized allergic inflammation rather than spasmodic
bronchoconstriction rendered the inhalation of smoke, even for therapeutic purposes,
problematic. As a number of medical authors had pointed out since the mid-nineteenth
century, smoke irritated the bronchial tree and often exacerbated the symptoms of
respiratory disease. In 1911, J B Berkart, physician to the City of London Hospital for
Diseases of the Chest, warned asthmatics of the dangers of commercially available
asthma cigarettes and powders, “the smoke of which, when inhaled, intensely irritates
the bronchial mucous membrane”, resulting in “fresh inflammation”.
67 Some years later,
the gastroenterologist Arthur Hurst, who was asthmatic himself and who became one of
the founding members of the Asthma Research Council in 1927, reinforced Berkart’s
reservations: “No patient should be allowed to use any of the numerous powders which
are used by inhaling the fumes produced when they are burnt, as they invariably aggra-
vate any bronchitis which may be present, and actually give rise to bronchitis in patients
who have hitherto been free from it.”
68
64Eric K Chu and Jeffrey M Drazen, ‘Asthma:
one hundred years of treatment and onward’, Am. J.
Respir. Crit. Care Med., 2005, 171: 1202–8.
Stramonium was also recommended for the treatment
of asthmatic children during the inter-war years: L A
Reynolds and E M Tansey (eds), Childhood asthma
and beyond, Wellcome Witnesses to Twentieth
Century Medicine, vol. 11, London, Wellcome Trust
Centre for the History of Medicine at UCL, 2001.
65H Herxheimer, ‘Atropine cigarettes in asthma
and emphysema’, Br. Med. J., 15 Aug. 1959, ii:
167–71, at p. 171. See also Harold A Abramson,
‘Therapy of asthma with reference to its
psychodynamic pharmacology’, Bull. N. Y. Acad.
Med., 1949, 25: 345–63.
66For further discussion, see Mark Jackson,
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Reaktion Books, 2006, pp. 27–55.
67Berkart, op. cit., note 57 above, p. 97.
68Arthur Hurst, ‘An address on asthma’, Lancet,
28 May 1921, i: 1113–17, at p. 1117.
The Rise and Fall of Smoking for Asthma
187During the middle decades of the twentieth century, allergists on both sides of the
Atlantic extended this advice and warned patients not only to avoid inhaling medicated
powders but also to limit their exposure to ordinary cigarette smoke that would irritate
their lungs and exacerbate their asthmatic symptoms. In 1941, for example, Warren T
Vaughan, one of the leading American allergists, suggested that tobacco was “a rather
common cause of inhalant allergy” and recommended desensitizing injections in cases
where patients or their partners could not stop smoking.
69 Over subsequent years, the
concerns of allergists about the impact of cigarette smoke on asthmatic patients deep-
ened. In a book aimed at patients and their families published in 1976, Doris J Rapp
and A W Frankland warned that cigarette smoke “in a home, at work, and in a restaurant
or automobile can cause the eyes to run, the nose to block, and the chest to wheeze”.
“NO asthmatic”, they insisted, “should smoke and no parent should smoke in the
presence of his allergic child.”
70
The place of smoking in treatment regimes was also challenged by the emergence of
alternative remedies for asthma. Stimulated partly by novel immunological accounts of
pathogenesis and partly by developments in pharmacology and the growth of the phar-
maceutical industry, a variety of new, and immediately more effective, treatments for
asthma were developed, marketed, prescribed and consumed during the early decades
of the twentieth century: atropine, which together with hyoscyamine and scopolamine
was one of the anticholinergic alkaloids derived from stramonium; adrenergic agents
such as adrenaline, derived from the adrenal glands, and ephedrine, which was isolated
from the Chinese herb ma huang; methylxanthines such as theophylline and aminophyl-
line; and oral steroids.
71 Offering both greater efficacy and reduced side-effects com-
pared with smoking stramonium, for both doctors and patients these new substances
became the mainstay of treatment. In 1935, George W Bray not only advocated the
use of adrenaline either alone or in conjunction with atropine and morphine for acute
attacks, but also strongly rejected the use of stramonium in the form of inhalations, pow-
ders, or cigarettes, since “the relief afforded is only temporary, and they have an extreme-
ly irritating effect on the bronchial mucous membrane; this, in turn, increases the liability
to further attacks”.
72 Although Bray recognized the value of tincture of stramonium,
incorporated in a bedtime linctus,
73 his reservations about the safety and efficacy of
smoking stramonium were reiterated by other medical writers. “Asthma powders, cigar-
ettes and sprays”, wrote the Indian physician Dharmendra in 1936, “have no place in the
treatment of acute attacks. In mild attacks they afford relief to some people but to others
the fumes from the powders and cigarettes may irritate the bronchial mucosa.”
74
Concerns about the adverse effects of smoking for asthma did not diminish clinical or
pharmaceutical interest in inhalational treatments in general. On the contrary, during the
middle decades of the twentieth century, major pharmaceutical companies strove to
69Warren T Vaughan, Strange malady: the story
of allergy, New York, Doubleday, Doran, 1941,
pp. 179–80.
70Doris J Rapp and A W Frankland, Allergies:
questions and answers, London, Heinemann, 1976,
pp. 34, 95; emphasis in original.
71See Jackson, op. cit., note 13 above.
72George W Bray, ‘The treatment of asthma’,
Br. Med. J., 19 Jan. 1935, i: 119–21.
73George W Bray, ‘The treatment of asthma’,
Post-grad. Med. J., Oct. 1935, 11: 339–45.
74Dharmendra, ‘Asthma’, Indian Med. Gaz.,
1936, 1: 279–84.
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188develop adrenergic agents and corticosteroids that were active when inhaled. The inhala-
tion of adrenaline in vaporized form, which offered an alternative to subcutaneous and
intravenous administration, was eventually displaced during the post-Second World
War years by the availability of increasingly selective inhaled bronchodilators, such as
isoprenaline and salbutamol. Indeed, the blue Ventolin Inhaler, containing salbutamol
and first marketed by Allen & Hanburys in 1969, became a prominent visual symbol
of rising levels of asthma in the modern world and nebulized salbutamol became increas-
ingly popular in the hospital treatment of acute asthma attacks.
75
The clinical and commercial success of inhaled bronchodilators encouraged industrial
efforts to develop inhaled steroids. Extracts from the adrenal cortex had been used to
treat asthma in the 1930s, but the results had been equivocal. By the 1940s, reports of
the efficacy of both synthetic cortisone and adreno-corticotrophic hormone (ACTH) in
moderating inflammation in patients with rheumatoid arthritis encouraged pharmaceuti-
cal companies to test those substances in asthmatics. During the 1950s, a number of
studies in Britain and North America demonstrated the value of oral and intramus-
cular cortisone in both acute and chronic asthma. Although the adverse effects assoc-
iated with long-term use of systemic steroids limited their clinical application, they did
encourage researchers to synthesize locally active compounds, such as beclomethasone,
marketed by Allen & Hanburys in 1972 as Becotide, for direct delivery to the lungs.
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Supported by dramatic improvements in inhaler technology, particularly by the intro-
duction of the pressurized metered-dose inhaler in 1956,
77 the development of novel
pharmacological approaches to the therapeutic and prophylactic management of asthma
clearly improved the prospects for patients with the condition. At the same time, the
emergence of selective bronchodilators and inhaled steroids during the 1960s and
1970s not only effectively marginalized smoking for asthma but also gradually displaced
the role of atropine in the treatment of acute attacks. By 1975, “belladonna alkaloids
were not considered a significant enough part of asthma treatment to be included” in
an American textbook of clinical medicine published that year.
78
Clinical attitudes towards smoking stramonium for asthma were also perhaps
adversely influenced by rising concerns about the health and economic impacts of smok-
ing other substances, such as opium, cannabis, and tobacco. Apprehensions about the
abuse of opium had escalated during the closing decades of the nineteenth century, lead-
ing to attempts, such as the Pharmacy Act of 1868, to regulate its sale and distribution
and to limit “the dreadful habit” of opium-smoking.
79 At the turn of the century, greater
international regulation of the opium trade, government inquiries into the commercial
consequences and medical benefits of opium and cannabis, and specific legislative inter-
ventions strove to distinguish more effectively between acceptable medical applications
and proscribed recreational use: the Pharmacy Act of 1908 and the Dangerous Drugs Act
of 1920 attempted to restrict the availability of opium, cannabis, and a range of other
75Jackson, op. cit., note 66 above, pp. 134–5;
Jackson, op. cit., note 13 above.
76Jackson, op. cit., note 66 above,
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77Sanders, op. cit., note 8 above; Anderson, op.
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78Chu and Drazen, op. cit., note 64 above. See
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10: 50–2.
79Smith, op. cit., note 50 above.
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189drugs for non-medical purposes. As a number of historians have suggested, such efforts
to police popular consumption of these substances were not always successful, but it is
likely that the gradual criminalization of smoking opium and cannabis also served to
undermine clinical and popular support for smoking stramonium.
80
Cultural dependence on, and commercial interests in, tobacco were also substantially
challenged during the mid-twentieth century, particularly by research published during
the 1950s that demonstrated an aetiological link between cigarette consumption and
lung cancer. Increasingly, smoking became the subject of scientific inquiries and health
education programmes organized by both government agencies and anti-tobacco or anti-
smoking movements.
81 As medical evidence of the respiratory effects and addictive qua-
lities of inhaled nicotine, tar and carbon monoxide intensified and as public and media
concerns about the tobacco industry proliferated, it became increasingly untenable to
advocate smoking for asthma. Although tobacco smoking was occasionally employed
as an expectorant in patients with bronchitis and other respiratory conditions,
82 smoking
carried distinct and evident health dangers for asthmatics. Echoing the advice of aller-
gists, in 1952 Gustavus Peters and his colleagues insisted that:
No patient who has asthma should smoke. Smoke of any type is irritating, not soothing, to mucous
membranes. Smoking induces cough, bronchitis, and bronchospasm, which are nature’s warning to
avoid or to expel the irritating effects of smoke. Likewise, any temporary benefit that patients
derive from smoking so-called asthma cigarettes or burning powders which contain stramonium
or nitrates, is nullified by the deleterious effect of the smoke itself, which aggravates the patients’
bronchitis. All patients with asthma have some degree of bronchitis . . . It should be axiomatic that
patients who have asthma should not smoke.
83
Intriguingly, waning medical and cultural support for smoking, as well as develop-
ments in understanding the pathology and treatment of asthma, did not completely excise
stramonium from the therapeutic arsenal. In response to growing political agitation and
declining cigarette consumption, the tobacco industry attempted to re-brand stramonium
and other medicated cigarettes as a deterrent for smoking. There had been suggestions in
the medical press during the 1940s that the side-effects of stramonium cigarettes, most
notably the dry mouth, could be exploited as a means of imparting a distaste for smoking
amongst those addicted: “Various preparations ...may have this effect”, wrote one cor-
respondent to the British Medical Journal in 1943, “and stramonium given in sufficient
dosage to cause dryness of the mouth may also act as a deterrent.”
84 The following
decade, cigarettes containing stramonium, or sometimes menthol, were again recommend-
ed on several occasions in the medical press as a means of “making the act of indulgence
so unpleasant that it is soon renounced”.
85
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190As the industry archives make clear, during subsequent decades multi-national tobacco
companies not only continued to promote stramonium cigarettes for the treatment of
asthma, but also explored a number of novel approaches to production and marketing
that might serve to protect their economic interests. In particular, they continued to
explore and advertise the role of medicated cigarettes in the management of addiction,
evaluated the potential benefits of grafting stramonium on to tobacco plants, a technique
developed by a Bulgarian company to produce Atrotabak,
86 and considered the develop-
ment of what were referred to as “health cigarettes” for dispensing a wide range of
drugs.
87 In certain locations, commercial interests were supported by statutory provi-
sions. In Britain, for example, the 1960 Poisons Rules exempted stramonium “cigarettes,
smoking mixtures or fumigants” from the restrictive provisions of the Poisons Act.
88
Equally, in some countries, cigarettes containing stramonium were subjected to much
lower rates of excise tax than other forms of smoking.
89
Industrial strategies were not always tolerated. Claims that herbal cigarettes were a
safer, and more culturally acceptable, form of smoking, for example, were certainly chal-
lenged on occasions: in 1980, M Robert Kaufman and Theodore Siek suggested that the
tobacco industry had exploited public interest in “natural” remedies and under-estimated
the toxic effects of the chemicals concerned, including regular anti-asthma ingredients
such as stramonium and lobelia.
90 Nevertheless, in spite of continuing concerns about
the health risks associated with medicated cigarettes and recurring public anxieties about
the lack of regulation of the sales of herbal cigarettes, particularly to children,
91 in some
ways the tobacco industry did relatively successfully, if only partially, convert the smok-
ing cure for asthma into a prospective, and potentially lucrative, cure for smoking.
During the middle decades of the twentieth century, a combination of novel theoretical
formulations of asthma, technical developments in treatment, the growing regulation of
smoking opium and cannabis, and shifting cultural attitudes to tobacco smoking collec-
tively served to undermine clinical support for smoking stramonium and other plant pre-
parations in order to relieve or prevent asthma attacks. This is not to say that scientific
and public interest (beyond the tobacco industry) evaporated entirely in the post-war
years: throughout the 1970s and 1980s, researchers continued sporadically to analyse
86See the articles and correspondence within the
British-American Tobacco Company on Atrotabak, in
the Legacy Tobacco Documents Library, available
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from H D Anderson to D G Felton, dated 11 April
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Bates nos. 400517305-400517347.
89See the entry on Greece in U.S. Department of
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Legacy Tobacco Documents Library, Bates no.
89609583/9694.
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“natural” always healthy?’, J. Sch. Health, Aug. 1980,
50: 322–5.
91See, for example, the evidence presented before
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191the physiological effects of asthma cigarettes.
92 Indeed, sustained by on-going public
consumption of popular anti-asthma remedies and perhaps by the promise of commercial
benefits, a number of studies persisted in emphasizing the efficacy and safety of medi-
cated cigarettes. In 1973, a German study reported that while regular tobacco cigarettes
triggered bronchoconstriction, asthma cigarettes containing atropine brought about “good
bronchodilation with minimal side effects”.
93 Five years earlier, a more idiosyncratic and
more passionate defence of herbal cigarettes had been published in the Journal of the
American Medical Association. Cubeb cigarettes, containing cubeb or tailed pepper,
stramonium, eucalyptus and other plant extracts, had been marketed for asthma, hay
fever, and catarrh since the mid-nineteenth century: indeed, Marshall’s, Blosser’s and
Dr Perrin’s cubeb cigarettes remained popular herbal brands well into the late twentieth
century. According to Virginia S Edwards, a doctor from Ohio who smoked cubeb cigar-
ettes herself, such products deserved to retain a critical place in the modern treatment of
respiratory disorders. “It is also my belief that the cubeb cigarette existed even prior to
the tobacco cigarette as a formal product, and was, as now, sold as a medicinal item,
advertised for bronchial asthma, hay fever, and colds, or just ‘across the counter’ as an
ordinary cigarette.” “Several local drugstores”, she concluded, “stock these cigarettes
for me and my patients. ‘Light up and live’.”
94
Conclusion
In recent years, expansive historical studies of smoking have focused critically on
scientific debates about the causal relationship between tobacco smoking and lung can-
cer, on the relative roles and responsibilities of the tobacco industry and state authorities,
and on the development of public health initiatives to combat the adverse health effects
of cigarette smoking.
95 These historiographical preoccupations are understandable: as
government reports and mortality statistics from around the world make clear, smoking
kills. However, there is an alternative history of smoking, namely as a therapeutic mea-
sure, which has only rarely been explored and which might offer insights into both the
history of smoking and the history of medicine. Enduring beliefs in the efficacy of the
smoking cure for asthma, for example, might help to explain persistent individual and
commercial commitments to smoking during the second half of the twentieth century.
At a broader level, careful historical explorations of treatments that seem antithetical
to modern political and professional sensibilities, or have become unfashionable, offer
constructive opportunities to reveal the contextual determinants of medical knowledge
and practice.
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192Although inhaling smoke, fumes and medicated vapours had been a recognized treat-
ment for asthma and other breathing difficulties since antiquity, the smoking cure
became increasingly fashionable amongst asthmatics and their doctors in the middle
decades of the nineteenth century. The rising popularity of smoking stramonium and
other herbal substances to relieve respiratory distress during that period owed much to
contemporary formulations of asthma as a condition marked by spasmodic bronchocon-
striction, as well as to firm endorsements from leading clinicians such as Henry Hyde
Salter. At the same time, the absence of alternative effective remedies and a growing cul-
tural dependence on smoking tobacco, opium and cannabis contributed to the increased
reliance of asthmatics such as Marcel Proust on stramonium cigarettes and powders.
During the early decades of the twentieth century, the prominent position of smoking
stramonium was challenged not only by new theories of asthma, which prioritized the
role of inflammation and regarded smoke as an irritant, but also by the proliferation of
novel and effective pharmaceutical remedies, by expanding state regulation of poisonous
substances such as opium and cannabis, and by growing concerns about the health
risks associated with smoking tobacco. Significantly, however, these factors did not
entirely undermine the place of medicated cigarettes in the treatment of asthma:
both clinicians and patients continued to rely on commercial powders and cigarettes
containing stramonium, cubeb, lobelia, potash and eucalyptus well into the 1980s and
1990s. In addition, of course, the therapeutic principles of smoking or inhalation as a
technique persisted in the form of inhalers designed to deliver bronchodilators, steroids
and other active substances to diseased lungs.
Perhaps ironically, the eventual demise of the smoking cure for asthma owed little to
health concerns about tobacco or to anxieties about the clinical effects of smoke on asth-
matic airways. During the late 1960s, reports in the Canadian medical press identified
what appeared to be a new danger of anti-asthma cigarettes. According to a number of
commentators, Canadian adolescents and young adults had begun “to abuse certain bel-
ladonna alkaloid drug products that are available, without prescription, for the inhalation
treatment of asthma”.
96 Cigarettes and powders containing stramonium, mostly notably
the Asthmador brand, were being crushed, mixed with water and ingested in order to
induce hallucinations; in some cases, acute intoxication and delirium resulted in admis-
sion to hospital and potential death. In subsequent years, similar reports of poisoning,
including occasional fatalities, appeared in the British and North American medical
press, particularly in relation to Potter’s Asthma Remedy and Surama cigarettes.
97
According to some alarmist reports, the fashion had been spread by word of mouth
at pop festivals, such as Knebworth, where stramonium had gained a reputation as
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193“a new type of ‘trip’ and a substance that did not make you vomit—unlike marijuana if
taken in excess”.
98
Of course, concerns about the hallucinogenic properties of thorn-apple were not new;
indeed, the psychoactive potential of preparations of Datura ferox and Datura stramo-
nium had been well-known, and regularly exploited for recreational and therapeutic pur-
poses, since antiquity. In the last decade of the twentieth century, however, growing
concerns about the health and economic impacts of drug abuse, as well as the wide avail-
ability of more effective and safer remedies for asthma, encouraged many commentators
to demand greater regulation and restriction of the sale of anti-asthma cigarettes and
powders.
99 While anti-asthma cigarettes have virtually disappeared under the weight of
such anxieties, the therapeutic principles of the smoking cure have not been entirely
eclipsed. At the start of the twenty-first century, inhaled treatments continue to dominate
the management of asthma, preparations of stramonium are still obtainable from herbal-
ists for the relief of respiratory conditions, a wide range of herbal cigarettes are available
both online and over the counter from newsagents and tobacconists, and anticholinergic
bronchodilators such as atropine and ipratropium bromide, initially derived or synthe-
sized from stramonium, are advocated for certain patients with asthma or chronic
obstructive pulmonary disease.
100 Although asthmatics no longer need to immerse them-
selves in clouds of smoke, as Marcel Proust did a century or so ago, the legacy of the
smoking cure for asthma persists.
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